GlassScriptPhysician profile
Nathan Allan Braden
NPI 1396231247
$1,112.76
in general payments reported to CMS, 2019-2025
15 companies · $712 in 2025
The $712 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $104 · 2024: $298 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $273.87 | 2024-2025 | |
| Lundbeck LLC | $173.07 | 2024-2025 | Abilify Maintena, Rexulti |
| Otsuka America Pharmaceutical, INC. | $159.81 | 2023-2025 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $93.98 | 2023-2025 | Uzedy |
| Indivior INC. | $92.08 | 2023-2025 | Perseris, Sublocade |
| Neurocrine Biosciences, INC. | $83.76 | 2023-2025 | Ingrezza |
| Ethicon US, LLC | $49.02 | 2025 | Echelon Flex |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.56 | 2024 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $30.39 | 2024-2025 | Cobenfy |
| Axsome Therapeutics, INC. | $28.76 | 2024-2025 | Auvelity |
| Vanda Pharmaceuticals INC. | $21.41 | 2025 | Fanapt |
| Supernus Pharmaceuticals, INC. | $19.94 | 2025 | Qelbree |
| Dexcom, INC. | $18.33 | 2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.04 | 2025 | Xifaxan |
| Xeris Pharmaceuticals, INC. | $14.74 | 2024 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Braden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.